EXHIBIT 10.17




--------------------------------------------------------------------------------



                 PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT

                                  by and among

                          Somanta Pharmaceuticals, Inc.

                                       and

              the parties named herein on Schedule 1, as Purchasers
                                          ----------







                                January 31, 2006



--------------------------------------------------------------------------------



<PAGE>

         This PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT is dated as of
January 31, 2006 (this "Agreement"), among Somanta Pharmaceuticals, Inc., a
Delaware corporation (the "Company"), and the purchasers identified on Schedule
1 hereto, as such schedule may be supplemented pursuant to Section 2.1(c) or
Section 6.15 below (each a "Purchaser" and collectively the "Purchasers").

         WHEREAS, subject to the terms and conditions set forth in this
Agreement and pursuant to Section 4(2) of the Securities Act (as defined below),
and Rule 506 promulgated thereunder, the Company desires to issue and sell to
the Purchasers, and the Purchasers, severally and not jointly, desire to
purchase from the Company in the aggregate up to 2,000 shares of the Company's
Series A Convertible Preferred Stock, and Warrants to purchase up to 20,000,000
shares of Common Stock (subject to adjustment for reverse and forward stock
splits, stock dividends, stock combinations and other similar transactions of
the Common Stock that occur after the date of the Initial Closing and prior to
an applicable Additional Closing), for an aggregate purchase price of up to
$20,000,000.

         NOW, THEREFORE, in consideration of the mutual covenants contained in
this Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and each Purchaser agree
as follows:

                                    ARTICLE I

                                   DEFINITIONS
                                   -----------

         1.1      Certain Definitions; Terms of Preferred Stock and Warrants.
                  ----------------------------------------------------------

         In addition to the terms defined elsewhere in this Agreement, for all
purposes of this Agreement, the following terms have the meanings indicated in
this Section 1.1:

         "Action" shall have the meaning ascribed to such term in Section
3.1(j).

         "Additional Closing" shall have the meaning ascribed to such term in
Section 2.1(c).

         "Additional Closing Escrow Agreement" shall have the meaning ascribed
to such term in Section 2.1(b).

         "Additional Purchasers" shall have the meaning ascribed to such term in
Section 2.1(c).

         "Additional Securities" shall have the meaning ascribed to such term in
Section 2.1(c).

         "Affiliate" means any Person that, directly or indirectly through one
or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 144. With
respect to a Purchaser, any investment fund or managed account that is managed
on a discretionary basis by the same investment manager as such Purchaser will
be deemed to be an Affiliate of such Purchaser.

         "Agreement" shall have the meaning ascribed to such term in the
Preamble.
<PAGE>

         "Business Day" means any day except Saturday, Sunday and any day which
shall be a federal legal holiday or a day on which banking institutions in the
State of New York are authorized or required by law or other governmental action
to close.

         "Certificate of Designation" shall have the meaning ascribed to such
term in Section 1.2.

         "Closing" shall have the meaning ascribed to such term in Section
2.1(a).

         "Closing Date" shall have the meaning ascribed to such term in Section
2.1(a).

         "Closing Escrow Agreement" shall have the meaning ascribed to such term
in Section 2.1(b).

         "Commission" means the Securities and Exchange Commission.

         "Common Stock" means the common stock of the Company, $0.001 par value
per share, and any securities into which such common stock may hereafter be
reclassified.

         "Common Stock Equivalents" means any securities of the Company or the
Subsidiaries which would entitle the holder thereof to acquire at any time
Common Stock, including without limitation, any debt, preferred stock, rights,
options, warrants or other instrument that is at any time convertible into or
exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.

         "Company" shall have the meaning ascribed to such term in the Preamble.

         "Conversion Shares" means the shares of Common Stock issuable or issued
upon conversion of the Preferred Stock.

         "Disclosure Schedules" means the Disclosure Schedules concurrently
delivered herewith.

         "Effective Date" means the date that the Registration Statement is
first declared effective by the Commission.

         "Environmental Laws" shall have the meaning ascribed to such term in
Section 3.1(y).

         "Exchange Act" means the Securities Exchange Act of 1934, as amended.

         "GAAP" shall have the meaning ascribed to such term in Section 3.1(h).

         "Governmental Authorizations" shall have the meaning ascribed to such
term in Section 3.1(m).

         "Hazardous Substances" shall have the meaning ascribed to such term in
Section 3.1(y).

         "Indemnified Party" shall have the meaning ascribed to such term in
Section 5.3.

                                       3
<PAGE>

         "Indemnifying Party" shall have the meaning ascribed to such term in
Section 5.3.

         "Initial Closing" shall have the meaning ascribed to such term in
Section 2.1(a).

         "Initial Closing Date" shall have the meaning ascribed to such term in
Section 2.1(a).

         "Intellectual Property" shall have the meaning ascribed to such term in
Section 3.1(o).

         "Investor Rights Agreement" means the Investor Rights Agreement between
the Company and each of the Purchasers, in the form of Exhibit A hereto.

         "Lien" means a lien, charge, security interest, encumbrance, right of
first refusal or other restriction, except for a lien for current taxes not yet
due and payable and a minor imperfection of title, if any, not material in
nature or amount and not materially detracting from the value or impairing the
use of the property subject thereto or impairing the operations or proposed
operations of the Company.

         "Material Adverse Effect" shall have the meaning ascribed to such term
in Section 3.1(b).

         "Per Share Purchase Price" equals $10,000.

         "Person" means an individual or corporation, partnership, trust,
incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof)
or other entity of any kind.

         "Placement Agent Warrants" means the common stock purchase warrants to
be issued at the Closing to SCO Securities LLC and/or their designees as
compensation for services rendered in connection with the transaction set forth
herein as provided on Schedule 1 attached hereto, which warrants shall be in the
form of Exhibit C hereto.

         "Preferred Shares" means the shares of Preferred Stock issued to each
Purchaser pursuant to this Agreement.

         "Preferred Stock" means the Company's Series A Convertible Preferred
Stock, par value $0.001 per share.

         "Premises" shall have the meaning ascribed to such term in Section
3.1(y).

         "Promissory Note" shall mean that certain Secured Convertible
Promissory Note due August 23, 2006, issued by Somanta Incorporated in favor of
SCO, as same was amended and restated on November 8, 2005 and as it may be
further amended from time to time.


         "Purchase Price" means the aggregate purchase price paid by each
Purchaser for the shares of Preferred Stock and Warrants purchased by such
Purchaser hereunder.

         "Purchaser" shall have the meaning ascribed to such term in the
Preamble.

         "Registration Statement" means a registration statement meeting the
requirements set forth in the Investor Rights Agreement and covering the resale
by the Purchasers of the Shares and the Warrant Shares.

         "Rights" shall have the meaning ascribed to such term in Section
3.1(o).

                                       4
<PAGE>

         "Rule 144" means Rule 144 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the
same effect as such Rule.

         "SCO" means SCO Capital Partners LLC.

         "SEC Reports" shall have the meaning ascribed to such term in Section
3.1(h).

         "Securities" means the Preferred Shares, the Conversion Shares, the
Warrants and the Warrant Shares.

         "Securities Act" means the Securities Act of 1933, as amended.

         "Somanta Incorporated" shall have the meaning ascribed to such term in
Section 2.2(e).

         "Subscription Amount" means, as to each Purchaser, the amount set forth
beside such Purchaser's name on Schedule 1 hereto, in United States dollars and
in immediately available funds, provided, however, that a portion of the amount
set forth beside SCO's name, as expressly indicated on Schedule 1 hereto shall
be payable in the form of the surrender and cancellation of the Promissory Note.

         "Subsidiary" means, with respect to any entity, any corporation or
other organization of which securities or other ownership interest having
ordinary voting power to elect a majority of the board of directors or other
persons performing similar functions, are directly or indirectly owned by such
entity or of which such entity is a partner or is, directly or indirectly, the
beneficial owner of 50% or more of any class of equity securities or equivalent
profit participation interests.

         "Trading Day" means (i) a day on which the Common Stock is traded on a
Trading Market, or (ii) if the Common Stock is not listed on a Trading Market, a
day on which the Common Stock is traded on the over-the-counter market, as
reported by the OTC Bulletin Board, or (iii) if the Common Stock is not quoted
on the OTC Bulletin Board, a day on which the Common Stock is quoted in the
over-the-counter market as reported by the National Quotation Bureau
Incorporated (or any similar organization or agency succeeding to its functions
of reporting prices); provided, that in the event that the Common Stock is not
listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day
shall mean a Business Day.

         "Trading Market" means the following markets or exchanges on which the
Common Stock is listed or quoted for trading on the date in question: the
American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, or the Nasdaq Capital Market.

         "Transaction Documents" means this Agreement, the Certificate of
Designation, the Investor Rights Agreement, the Warrants and any other documents
or agreements executed in connection with the transactions contemplated
hereunder.

         "Warrants" means the Common Stock Purchase Warrants, in the form of
Exhibit B hereto. The Placement Agent Warrants shall also constitute "Warrants"
for all purposes hereunder and SCO Securities LLC and/or its designees shall
constitute "Purchasers" for all purposes hereunder.

         "Warrant Shares" means the shares of Common Stock issuable upon
exercise of the Warrants.

                                       5
<PAGE>

         1.2      Terms of the Preferred Stock and Warrants. The terms and
provisions of the Preferred Stock are set forth in the form of Certificate of
Designations of Rights and Preferences of Series A Convertible Preferred Stock,
attached hereto as Exhibit D (the "Certificate of Designation"). The terms and
provisions of the Warrants are as set forth in the form of Common Stock Purchase
Warrant, attached hereto as Exhibit B (and Exhibit C in the case of the
Placement Agent Warrants).

                                   ARTICLE II

                                PURCHASE AND SALE
                                -----------------

         2.1      Closing.
                  -------

         (a)      The initial closing of the transactions contemplated under
this Agreement (the "Initial Closing") will take place as promptly as
practicable, but no later than five (5) Business Days following satisfaction or
waiver of the conditions set forth in Sections 2.2 and 2.3 (other than those
conditions which by their terms are not to be satisfied or waived until the
Initial Closing), at the offices of Wiggin and Dana LLP, 400 Atlantic Street,
Stamford, CT 06901 (or remotely via exchange of documents and signatures) or at
such other place or day as may be mutually acceptable to the Purchasers and the
Company. The date on which the Initial Closing occurs is the "Initial Closing
Date". Any Additional Closing (as defined below) will take place at the offices
of Wiggin and Dana LLP, 400 Atlantic Street, Stamford, CT 06901 (or remotely via
exchange of documents and signatures) or at such other place and on such date as
may be mutually acceptable to the Purchasers in such Additional Closing and the
Company. The date on which the Additional Closing occurs is the "Additional
Closing Date." The term "Closing" shall refer to the Initial Closing and any
Additional Closing, the term "Closing Date" shall refer to the Initial Closing
Date or the Additional Closing Date, as applicable.

         (b)      At the Initial Closing, the Purchasers shall purchase,
severally and not jointly, and the Company shall issue and sell, in the
aggregate, 592.6318 shares of Preferred Stock and Warrants to purchase 5,962,317
shares of Common Stock on the Initial Closing Date. At the Initial Closing and
any Additional Closing, each Purchaser shall purchase from the Company, and the
Company shall issue and sell to each Purchaser, a number of Preferred Shares
equal to such Purchaser's Subscription Amount divided by the Per Share Purchase
Price and a Warrant to purchase 50% of the number of Conversion Shares into
which such Preferred Shares purchased by such Purchaser are then convertible
(rounded up to the nearest whole share). On the date hereof, the Subscription
Amount paid by each Purchaser in the Initial Closing shall be placed in escrow
pending the Initial Closing pursuant to a Closing Escrow Agreement among the
Company, SCO Securities LLC and Wiggin and Dana LLP (the "Escrow Agent"), which
agreement shall be in the form attached hereto as Exhibit E (the "Closing Escrow
Agreement"). Subscription Amounts paid by Purchasers in any Additional Closing
shall be placed in escrow pending such Additional Closing pursuant to an escrow
agreement in a form substantially similar to the Closing Escrow Agreement, with
such changes as may be necessary or appropriate to account for the Additional
Closing (the "Additional Closing Escrow Agreement").

                                       6
<PAGE>

         (c)      After the Initial Closing, the Company may sell up to
1,407.3682 additional shares of Preferred Stock and additional Warrants to
purchase up to 14,073,683 shares of Common Stock (subject to adjustment for
reverse and forward stock splits, stock dividends, stock combinations and other
similar transactions of the Common Stock that occur after the Initial Closing
and prior to the applicable Additional Closing) (the "Additional Securities"),
to one or more purchasers (the "Additional Purchasers") as are mutually agreed
upon by the Company and SCO Securities LLC, provided that (i) all such
subsequent sale(s) (each an "Additional Closing") are consummated prior to 30
days after the Initial Closing or at such later time as mutually agreed to by
the Company and SCO Securities LLC and (ii) each Additional Purchaser shall
become a party to this Agreement and the Investor Rights Agreement, by executing
and delivering a counterpart signature page thereto. Schedule 1 to this
Agreement shall be supplemented to reflect the number of Additional Securities
purchased at each such Additional Closing and to reflect the parties purchasing
such Additional Securities.

         (d)      The Purchasers party to this Agreement hereby (i) irrevocably
waive any preemptive rights, rights of first offer, rights of first refusal,
participation rights, anti-dilution rights or other similar rights they may
possess now or hereafter, pursuant to the terms of any agreement with the
Company or otherwise, with respect to sales of Additional Securities made
pursuant to this Agreement and (ii) consent to the joinder of any Additional
Purchasers to this agreement.

         2.2      Conditions to Obligations of Purchasers to Effect the Closing.
                  -------------------------------------------------------------

         The obligations of each Purchaser to effect any Closing and the
transactions contemplated by this Agreement shall be subject to the satisfaction
at or prior to such Closing of each of the following conditions, any of which
may be waived, in writing, by such Purchaser:

         (a)      At the Closing (unless otherwise specified below) the Company
shall deliver or cause to be delivered to each Purchaser the following:

                  (i)      this Agreement, duly executed by the Company;

                  (ii)     a certificate evidencing a number of Preferred Shares
equal to such Purchaser's Subscription Amount divided by the Per Share Purchase
Price as set forth on Schedule 1 hereto, registered in the name of such
Purchaser;

                  (iii)    a Warrant, registered in the name of such Purchaser,
pursuant to which such Purchaser shall have the right to acquire up to the
number of shares of Common Stock equal to 50% of the shares of Common Stock
issuable upon conversion of the Preferred Shares to be issued to such Purchaser
at such Closing, as set forth on Schedule 1 hereto;

                  (iv)     the Investor Rights Agreement, duly executed by the
Company;

                                       7
<PAGE>

                  (v)      a legal opinion of Foley & Lardner LLP, counsel to
the Company, in the form of Exhibit E hereto, as of the date of the Initial
Closing; -

                  (vi)     a certificate of the Secretary of the Company (the
"Secretary's Certificate"), as of the date of the applicable Closing, attaching
a true copy of the Certificate of Incorporation and Bylaws of the Company, as
amended to such applicable Closing Date, and attaching true and complete copies
of the resolutions of the Board of Directors of the Company authorizing the
execution, delivery and performance of this Agreement and the other Transaction
Documents;

                  (vii)    a certificate of the chief executive officer,
president or chief financial officer of the Company, as of the applicable
Closing Date, certifying that the representations and warranties of the Company
contained Sections 3.1(b), (c), (d), (e), (f), (h), (r), (z) and (aa) herein are
true and correct as of such applicable Closing Date as though such
representations and warranties were made on such date (except those
representations and warranties that address matters only as of a particular date
which shall be true and correct as of such date); and

                  (viii)   evidence satisfactory to the Purchasers that the
Certificate of Designation was duly filed with the Secretary of State of the
State of Delaware.

         (b)      Each of Agamemnon A. Epenetos, Terrance J. Bruggeman, Luiz
Porto, Gary Bower, John Gibson, Michael Ashton, David Kramer and Kathleen
VanSleen, together with any person or entity through which such persons
beneficially own shares of the Company's Common Stock, shall have entered into a
lock-up agreement in the form attached as Exhibit F hereto. In addition, Jeffrey
B. Davis shall have entered into a substantially similar lock-up agreement,
provided, however, that such lock-up agreement shall apply only to shares of the
Company's Common Stock held by him personally and not to any shares held by any
affiliate, person or entity through which Mr. Davis may beneficially own shares
of the Company's Common Stock.

         (c)      As of the applicable Closing Date, there shall have been no
Material Adverse Effect with respect to the Company since the date hereof.

         (d)      From the date hereof to the applicable Closing Date, trading
in the Common Stock shall not have been suspended by the Commission (except for
any suspension of trading of limited duration agreed to by the Company, which
suspension shall be terminated prior to the Closing), and, at any time prior to
such applicable Closing Date, trading in securities generally as reported by
Bloomberg Financial Markets shall not have been suspended or limited, or minimum
prices shall not have been established on securities whose trades are reported
by such service, or on any Trading Market, nor shall a banking moratorium have
been declared either by the United States or New York State authorities.

         (e)      The Company will have timely filed with the Commission the
financial statements and pro forma financial information required under Item
9.01 of Form 8-K with respect to Somanta Incorporated, a Delaware corporation
("Somanta Incorporated") and such Current Report on Form 8-K shall be in
compliance with the requirements of the Exchange Act and the rules and
regulations of the Commission promulgated thereunder and such financial
statements shall not differ materially from the financial statements of Somanta
Incorporated provided to the Purchasers. The failure to make such filing on a
timely basis shall constitute a material breach of this Agreement and shall

                                       8
<PAGE>

allow each Purchaser to withdraw from this Agreement without liability to the
Company, any other Purchaser or to SCO Securities LLC as placement agent.

         (f)      Either (i) the Company's Common Stock shall be quoted on the
OTC Bulletin Board or listed on a Trading Market or (ii) the Company shall have
provided evidence, satisfactory to the Purchasers, that the Company is, as of
the Initial Closing Date, able to meet all of the requirements to permit a
market maker to quote the Company's Common Stock on the OTC Bulletin Board.

         (g)      The Company shall have entered into the Closing Escrow
Agreement.

         2.3.     Conditions to Obligations of the Company to Effect the
                  Closing.
                  ------------------------------------------------------

         The obligations of the Company to effect any Closing and the
transactions contemplated by this Agreement shall be subject to the satisfaction
at or prior to such Closing of each of the following conditions, any of which
may be waived, in writing, by the Company.

         (a)      At the Closing, each Purchaser shall deliver or cause to be
delivered to the Company the following:

                  (i)      this Agreement, duly executed by such Purchaser;

                  (ii)     such Purchaser's Subscription Amount, by wire
transfer of immediately available funds or, in the case of the Promissory Note,
by the delivery thereof as provided in the Closing Escrow Agreement or the
Additional Closing Escrow Agreement, as applicable; and

                  (iii)    the Investor Rights Agreement, duly executed by such
Purchaser.

         (b)      All representations and warranties of such Purchaser contained
herein shall be true and correct as of the applicable Closing Date as though
such representations and warranties were made on such date.

                                   ARTICLE III

                         REPRESENTATIONS AND WARRANTIES
                         ------------------------------

         3.1      Representations and Warranties of the Company.
                  ---------------------------------------------

         Except as set forth under the corresponding section of the Disclosure
Schedules delivered concurrently herewith, the Company hereby makes the
following representations and warranties as of the date hereof to each
Purchaser:

         (a)      Subsidiaries. Except as listed in Schedule 3.1(a), the Company
has no direct or indirect Subsidiaries.

         (b)      Organization and Qualification. Each of the Company and the
Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its

                                       9
<PAGE>

incorporation or organization (as applicable), with the requisite corporate
power and authority to own and use its properties and assets and to carry on its
business as currently conducted. Neither the Company nor any Subsidiary is in
violation of any of the provisions of its respective certificate or articles of
incorporation, bylaws or other organizational or charter documents. Each of the
Company and the Subsidiaries is duly qualified to conduct business and is in
good standing as a foreign corporation or other entity in each jurisdiction in
which the nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so qualified or in good
standing, as the case may be, has not had or resulted in and would not have or
result in (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Document, (ii) a material adverse effect on
the results of operations, assets, business or financial condition of the
Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company's ability to perform on a timely basis its obligations
under any Transaction Document (any of (i), (ii) or (iii), a "Material Adverse
Effect").

         (c)      Authorization; Enforceability. The Company has the requisite
corporate power and authority to enter into and to consummate the transactions
contemplated by each of the Transaction Documents and otherwise to carry out its
obligations thereunder. The execution and delivery of each of the Transaction
Documents by the Company and the consummation by it of the transactions
contemplated thereby (including, but not limited to, the sale and delivery of
the Preferred Stock and Warrants) have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company, its Board of Directors or its shareholders in connection therewith. The
issuance and delivery of the Conversion Shares upon conversion of the Preferred
Stock and the Warrant Shares upon exercise of the Warrants have been duly
authorized by all necessary action on the part of the Company and no further
action is required by the Company, its Board of Directors or its shareholders in
connection therewith. Each Transaction Document has been (or upon delivery will
have been) duly executed by the Company and, when delivered in accordance with
the terms hereof, will constitute the valid and binding obligation of the
Company enforceable against the Company in accordance with its terms, subject to
laws of general application relating to bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting creditors' rights generally and rules
of law governing specific performance, injunctive relief, or other equitable
remedies.

         (d)      No Conflicts. The execution, delivery and performance of the
Transaction Documents by the Company and the consummation by the Company of the
transactions contemplated thereby do not and will not (i) conflict with or
violate any provision of the Company's or any Subsidiary's certificate or
articles of incorporation, bylaws or other organizational or charter documents,
or (ii) conflict with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, or give to others any
rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other
instrument (evidencing a Company or Subsidiary debt or otherwise) or other
understanding to which the Company or any Subsidiary is a party or by which any
property or asset of the Company or any Subsidiary is bound or affected, or
(iii) result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state
securities laws and regulations), or by which any property or asset of the
Company or a Subsidiary is bound or affected, except, in the cases of clause
(ii), where such conflict, default or violation would not have or result in a
Material Adverse Effect.

                                       10
<PAGE>

         (e)      Filings, Consents and Approvals. The Company is not required
to obtain any consent, waiver, authorization or order of, give any notice to, or
make any filing or registration with, any court or other federal, state, local
or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents,
other than (a) the filing with the Commission of the Registration Statement, the
application(s) to each Trading Market for the listing of the Conversion Shares
and Warrant Shares for trading thereon in the time and manner required thereby,
Form D and applicable Blue Sky filings, (b) the filing of a Current Report on
Form 8-K pursuant to Section 4.5 and (c) such as have already been obtained or
such exemptive filings as are required to be made under applicable securities
laws.

         (f)      Issuance of the Securities. The Preferred Shares, Warrant
Shares and Conversion Shares are duly authorized and, when issued and paid for
in accordance with the Transaction Documents, (i) will be duly and validly
issued, fully paid and nonassessable, free and clear of all Liens, other than
any Liens created by or imposed on the holders thereof through no action of the
Company and (ii) will be free of, and have not been issued in violation of, any
preemptive rights, rights of first refusal, co-sale rights or similar rights
pursuant to any law or any agreement to which the Company is a party. The
Warrants are duly authorized and, when issued and paid for in accordance with
the Transaction Documents, (i) will be duly and validly issued and free and
clear of all Liens, other than any Liens created by or imposed on the holders
thereof through no action of the Company and (ii) will be free of, and have not
been issued in violation of, any preemptive rights, rights of first refusal,
co-sale rights or similar rights pursuant to any law or any agreement to which
the Company is a party. The Company has reserved from its duly authorized
capital stock (i) the maximum number of shares of Preferred Stock issuable
pursuant to this Agreement and (ii) the maximum number of shares of Common Stock
issuable upon conversion of the Preferred Stock and exercise of the Warrants.

         (g)      Capitalization.

                  (i)      Including shares issued in connection with the
acquisition of all of the capital stock of Somanta Incorporated, the entire
authorized capital stock of the Company consists of (A) 100,000,000 shares of
Common Stock, 14,274,352 of which are issued and outstanding, and (B) 20,000,000
shares of Preferred Stock, none of which are issued and outstanding, and 2000 of
which have been designated as Series A Convertible Preferred Stock. All shares
of the Company's issued and outstanding capital stock have been duly authorized,
are validly issued and outstanding, and are fully paid and nonassessable. No
securities issued by the Company from the date of its incorporation to the date
hereof were issued in violation of any statutory or common law preemptive
rights. There are no dividends which have accrued or been declared but are
unpaid on the capital stock of the Company. All taxes required to be paid by the
Company in connection with the issuance and any transfers of the Company's
capital stock have been paid. All securities of the Company have been issued in
all material respects in accordance with the provisions of all applicable
securities and other laws.

                  (ii)     No Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate in the
transactions contemplated by the Transaction Documents. Except as a result of
the purchase and sale of the Securities and except as set forth on Schedule
3.1(g)(i), there are no outstanding options, warrants, rights to subscribe to,
calls or commitments of any character whatsoever relating to, or securities,

                                       11
<PAGE>

rights or obligations convertible into or exchangeable for, or giving any Person
any right to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to issue additional shares of Common Stock, or
securities or rights convertible or exchangeable into shares of Common Stock.
The issue and sale of the Securities will not obligate the Company to issue
shares of Common Stock or other securities to any Person (other than the
Purchasers) and will not result in a right of any holder of Company securities
to adjust the exercise, conversion, exchange or reset price under such
securities.

         (h)      SEC Reports; Financial Statements; Liabilities.

                  (i)      The Company has filed all reports required to be
filed by it under the Securities Act and the Exchange Act, including pursuant to
Section 13(a) or 15(d) of the Exchange Act, for the 12 months preceding the date
hereof (or such shorter period as the Company was required by law to file such
material) (the foregoing materials, including the exhibits thereto, being
collectively referred to herein as the "SEC Reports") on a timely basis or has
received a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension. As of their respective
filing dates, the SEC Reports complied in all material respects with the
requirements of the Securities Act and the Exchange Act, as the case may be, and
the rules and regulations of the Commission promulgated thereunder, as
applicable, and none of the SEC Reports, as of their respective filing dates,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading.

                  (ii)     The financial statements of the Company and any
acquired entities included in the SEC Reports comply with applicable accounting
requirements and the rules and regulations of the Commission with respect
thereto as in effect at the time of filing. Such financial statements have been
prepared in accordance with generally accepted accounting principles in the
United States, applied on a consistent basis during the periods involved
("GAAP"), except as may be otherwise specified in such financial statements or
the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, subject to normal year-end audit adjustments.
Such financial statements fairly present in all material respects the financial
position of the Company and its consolidated subsidiaries, if any, as of and for
the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal year-end
audit adjustments.

                  (iii)    Except as set forth in the SEC Reports, and except
for liabilities and obligations incurred since April 30, 2005 in the ordinary
course of business, consistent with past practice, as of the date hereof: (i)
the Company and its Subsidiaries do not have any material liabilities or
obligations (absolute, accrued, contingent or otherwise) and (ii) there has not
been any aspect of the prior or current conduct of the business of the Company
or its Subsidiaries which may form the basis for any material claim by any third
party which if asserted could result in a Material Adverse Effect.

         (i)      Material Changes. Since April 30, 2005 and except as set forth
in the SEC Reports and on Schedule 3.1(i), the Company has conducted its
business only in the ordinary course, consistent with past practice, and there
has not occurred:

                                       12
<PAGE>

                  (i)      any event that could have a Material Adverse Effect
on the Company or any of its Subsidiaries;

                  (ii)     any amendments or changes in the charter documents of
the Company and its Subsidiaries;

                  (iii)    any damage, destruction or loss, whether or not
covered by insurance, that would, individually or in the aggregate, have or
would be reasonably likely to have, a Material Adverse Effect on the Company and
its Subsidiaries;

                  (iv)     any:

                           (A) incurrence, assumption or guarantee by the
Company or its Subsidiaries of any debt for borrowed money other than (i)
equipment leases made in the ordinary course of business, consistent with past
practice and (ii) any such incurrence, assumption or guarantee with respect to
an amount of $25,000 or less that has been disclosed in the SEC Reports;

                           (B) issuance or sale of any securities convertible
into or exchangeable for securities of the Company other than to directors,
employees and consultants pursuant to existing equity compensation or stock
purchase plans of the Company;

                           (C) issuance or sale of options or other rights to
acquire from the Company or its Subsidiaries, directly or indirectly, securities
of the Company or any securities convertible into or exchangeable for any such
securities, other than options issued to directors, employees and consultants in
the ordinary course of business, consistent with past practice;

                           (D) issuance or sale of any stock, bond or other
corporate security other than to directors, employees and consultants pursuant
to existing equity compensation or stock purchase plans of the Company;

                           (E) discharge or satisfaction of any material Lien of
the Company or its Subsidiaries;

                           (F) declaration or making any payment or distribution
to stockholders or purchase or redemption of any share of its capital stock or
other security other than to directors, officers and employees of the Company or
its Subsidiaries as compensation for services rendered to the Company or its
Subsidiary (as applicable) or for reimbursement of expenses incurred on behalf
of the Company or its Subsidiary (as applicable);

                           (G) sale, assignment or transfer of any of the
intangible assets of the Company or its Subsidiaries except in the ordinary
course of business, consistent with past practice, or cancellation of any debt
or claim except in the ordinary course of business, consistent with past
practice;

                           (H) waiver of any right of substantial value of the
Company or its Subsidiaries whether or not in the ordinary course of business;

                                       13
<PAGE>

                           (I) material change in officer compensation of the
Company or its Subsidiaries, except in the ordinary course of business and
consistent with past practice; or

                           (J) other commitment (contingent or otherwise) of the
Company or its Subsidiaries to do any of the foregoing.

                  (v)      any creation, sufferance or assumption by the Company
or any of its Subsidiaries of any Lien on any asset or any making of any loan,
advance or capital contribution to or investment in any Person, in an aggregate
amount which exceeds $25,000 outstanding at any time;

                  (vi)     any entry into, amendment of, relinquishment,
termination or non-renewal by the Company or its Subsidiaries of any material
contract, license, lease, transaction, commitment or other right or obligation,
other than in the ordinary course of business, consistent with past practice; or

                  (vii)    any transfer or grant of a right with respect to the
patents, trademarks, trade names, service marks, trade secrets, copyrights or
other intellectual property rights owned or licensed by the Company or its
Subsidiaries, except as among the Company and its Subsidiaries.

         (j)      Litigation. There is no action, suit, inquiry, notice of
violation, proceeding or investigation pending or, to the knowledge of the
Company or its Subsidiaries, threatened against the Company, any Subsidiary or
any of their respective properties before or by any court, arbitrator,
governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an "Action") which (i) adversely
affects or challenges the legality, validity or enforceability of any of the
Transaction Documents or the Securities or (ii) could, if there were an
unfavorable decision, have or result in a Material Adverse Effect. Neither the
Company nor any Subsidiary, nor, to the knowledge of the Company or its
Subsidiaries, any director or officer thereof, is or has been the subject of any
Action involving a claim of violation of or liability under federal or state
securities laws or a claim of breach of fiduciary duty. To the knowledge of the
Company or its Subsidiaries, there has not been and there is not pending or
contemplated, any investigation by the Commission involving the Company or its
Subsidiaries or any current or former director or officer of the Company or its
Subsidiaries. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company
or any Subsidiary under the Exchange Act or the Securities Act.

         (k)      Labor Relations. No material labor dispute exists or, to the
knowledge of the Company or its Subsidiaries, is imminent with respect to any of
the employees of the Company or its Subsidiaries which could have or result in a
Material Adverse Effect.

         (l)      Compliance. Neither the Company nor any Subsidiary (i) is in
default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by
the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in
violation of, any indenture, loan or credit agreement or any other agreement or
instrument to which it is a party or by which it or any of its properties is
bound (whether or not such default or violation has been waived), (ii) is in
violation of any order of any court, arbitrator or governmental body, or (iii)

                                       14
<PAGE>

is or has been in violation of any statute, rule or regulation of any
governmental authority, including without limitation all foreign, federal, state
and local laws applicable to its business, except in the case of clauses (i) and
(iii) as would not have or reasonably be expected to result in a Material
Adverse Effect.

         (m)      Licenses; Compliance With Regulatory Requirements. The Company
and its Subsidiaries hold all material authorizations, consents, approvals,
franchises, licenses and permits required under applicable law or regulation for
the operation of the business of the Company and its Subsidiaries as presently
operated (the "Governmental Authorizations"). All the Governmental
Authorizations have been duly issued or obtained and are in full force and
effect, and the Company and its Subsidiaries are in material compliance with the
terms of all the Governmental Authorizations. The Company and its Subsidiaries
have not engaged in any activity that, to their knowledge, would cause
revocation or suspension of any such Governmental Authorizations. The Company
has no knowledge of any facts which could reasonably be expected to cause the
Company to believe that the Governmental Authorizations will not be renewed by
the appropriate governmental authorities in the ordinary course. Neither the
execution, delivery nor performance of this Agreement shall adversely affect the
status of any of the Governmental Authorizations.

         (n)      Title to Assets. The Company and the Subsidiaries do not own
any real property, and have good and marketable title to all personal property
owned by them that is material to the business of the Company and the
Subsidiaries, taken as a whole, in each case free and clear of all Liens, except
those, if any, reflected in the Company's financial statements. Any real
property and facilities held under lease by the Company and the Subsidiaries are
held by them under valid, subsisting and enforceable leases (subject to laws of
general application relating to bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting creditors' rights generally and rules
of law governing specific performance, injunctive relief, or other equitable
remedies) with which the Company and the Subsidiaries are in material
compliance.

         (o)      Intellectual Property.

                  (i)      The Company or a Subsidiary thereof has the right to
use or is the sole and exclusive owner of all right, title and interest in and
to all foreign and domestic patents, patent rights, trademarks, service marks,
trade names, brands and copyrights (whether or not registered and, if
applicable, including pending applications for registration) owned, used or
controlled by the Company and its Subsidiaries (collectively, the "Rights") and
in and to each material invention, software, trade secret, technology, product,
composition, formula and method of process used by the Company or its
Subsidiaries (the Rights and such other items, the "Intellectual Property"),
and, to the Company's and its Subsidiaries' knowledge, has the right to use the
same, free and clear of any claim or conflict with the rights of others;

                  (ii)     other than as set forth in the SEC Reports, no
royalties or fees (license or otherwise) are payable by the Company or its
Subsidiaries to any Person by reason of the ownership or use of any of the
Intellectual Property;

                  (iii)    there have been no claims made against the Company or
its Subsidiaries asserting the invalidity, abuse, misuse, or unenforceability of
any of the Intellectual Property, and, to the best of the Company's knowledge,
there are no reasonable grounds for any such claims;

                                       15
<PAGE>

                  (iv)     neither the Company nor its Subsidiaries have made
any claim of any violation or infringement by others of its rights in the
Intellectual Property, and to the best of the Company's knowledge, no reasonable
grounds for such claims exist; and

                  (v)      neither the Company nor its Subsidiaries have
received notice that it is in conflict with or infringing upon the asserted
rights of others in connection with the Intellectual Property.

         (p)      Insurance. The Company and the Subsidiaries are insured by
insurers of recognized financial responsibility against such losses and risks
and in such amounts as are prudent and customary in the businesses in which the
Company and the Subsidiaries are engaged. All of the insurance policies of the
Company and its Subsidiaries are in full force and effect and are valid and
enforceable in accordance with their terms, and the Company and its Subsidiaries
have complied with all material terms and conditions thereof. Neither the
Company nor any Subsidiary has any reason to believe that it will not be able to
renew its existing insurance coverage as and when such coverage expires or to
obtain similar coverage from similar insurers as may be necessary to continue
its business without a significant increase in cost.

         (q)      Transactions With Affiliates and Employees. Except as set
forth on Schedule 3.1(q), none of the officers or directors of the Company or
its Subsidiaries and, to the knowledge of the Company and its Subsidiaries, none
of the employees of the Company or its Subsidiaries is presently a party to any
transaction with the Company or any Subsidiary (other than for services as
employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for
rental of real or personal property to or from, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the
Company and its Subsidiaries, any entity in which any officer, director, or any
such employee has a substantial interest or is an officer, director, trustee or
partner, other than (a) for payment of salary or consulting fees for services
rendered, (b) reimbursement for expenses incurred on behalf of the Company and
(c) for other employee benefits, including stock option agreements and other
stock awards under any equity compensation plan of the Company.

         (r)      Internal Accounting Controls. The Company and each of the
Subsidiaries maintains a system of internal accounting controls sufficient in
the judgment of the Company's management to provide reasonable assurance that
(i) transactions are executed in accordance with management's general or
specific authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain
asset accountability, (iii) access to assets is permitted only in accordance
with management's general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The
Company has established disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the Company and designed such
disclosure controls and procedures to ensure that material information relating
to the Company, including its Subsidiaries, is made known to the certifying
officers by others within those entities, particularly during the period in
which the Company's Form 10-KSB or 10-QSB, as the case may be, is being
prepared. The Company's certifying officers have evaluated the effectiveness of

                                       16
<PAGE>

the Company's controls and procedures as of October 31, 2005. The Company will
present in its next Form 10-QSB, the conclusions of the certifying officers
about the effectiveness of the disclosure controls and procedures based on their
evaluations as of October 31, 2005. Since April 30, 2005, there have been no
significant changes in the Company's internal controls (as such term is defined
in Item 307(b) of Regulation S-K under the Exchange Act) or, to the Company's
knowledge, in other factors that could significantly affect the Company's
internal controls.

         (s)      Certain Fees. Except for fees payable to SCO Securities LLC,
no brokerage or finder's fees or commissions are or will be payable by the
Company or its Subsidiaries to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to
the transactions contemplated by this Agreement. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on
behalf of other Persons for fees of a type contemplated in this Section that may
be due in connection with the transactions contemplated by this Agreement.

         (t)      Private Placement; Integrated Offering. Assuming the accuracy
of the Purchasers representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the
Securities by the Company to the Purchasers as contemplated hereby. The issuance
and sale of the Securities hereunder does not contravene the rules and
regulations of the OTC Bulletin Board. Neither the Company, nor any of its
Affiliates, nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to
buy any security, under circumstances that would cause this offering of the
Securities to be integrated with prior offerings by the Company for purposes of
the Securities Act and would as a result require registration under the
Securities Act or trigger any applicable shareholder approval provisions,
including, without limitation, under the rules and regulations of any exchange
or automated quotation system on which any of the securities of the Company are
listed or designated.

         (u)      Charter, Bylaws and Corporate Records. The minute books of the
Company and its Subsidiaries contain in all material respects complete and
accurate records of all meetings and other corporate actions of the board of
directors, committees of the board of directors, incorporators and stockholders
of the Company and its Subsidiaries from the date of incorporation of each such
entity to the date hereof. All material corporate decisions and actions have
been validly made or taken. All corporate books, including without limitation
the share transfer register, comply in all material respects with applicable
laws and regulations and have been regularly updated.

         (v)      Registration Rights. Except as set forth in Schedule 3.1(v)
and under the Investor Rights Agreement, no Person has any right to cause the
Company to effect the registration under the Securities Act of any securities of
the Company.

         (w)      Listing and Maintenance Requirements. The Company has not, in
the 12 months preceding the date hereof, received notice from the OTC Bulletin
Board or any Trading Market on which the Common Stock is or has been listed or
quoted to the effect that the Company is not in compliance with the listing or
maintenance requirements of the OTC Bulletin Board or such Trading Market. The
Company is, and has no reason to believe that it will not in the foreseeable

                                       17
<PAGE>

future continue to be, in compliance with all such listing and maintenance
requirements.

         (x)      Taxes. All tax returns and tax reports required to be filed
with respect to the income, operations, business or assets of the Company and
its Subsidiaries have been timely filed (or appropriate extensions have been
obtained) with the appropriate governmental agencies in all jurisdictions in
which such returns and reports are required to be filed, and all of the
foregoing as filed are, in all material respects, correct and complete and, in
all material respects, reflect accurately all liability for taxes of the Company
and its Subsidiaries for the periods to which such returns relate, and all
amounts shown as owing thereon have been paid. All income, profits, franchise,
sales, use, value added, occupancy, property, excise, payroll, withholding,
FICA, FUTA and other taxes (including interest and penalties), if any,
collectible or payable by the Company and its Subsidiaries or relating to or
chargeable against any of its material assets, revenues or income or relating to
any employee, independent contractor, creditor, stockholder or other third party
through the Closing Date, were fully collected and paid by such date if due by
such date or provided for by adequate reserves in the financial statements
contained in the SEC Reports as of and for the periods ended June 30, 2005
(other than taxes accruing after such date) and all similar items due through
the Closing Date will have been fully paid by that date or provided for by
adequate reserves, whether or not any such taxes were reported or reflected in
any tax returns or filings. No taxation authority has sought to audit the
records of the Company or any of its Subsidiaries for the purpose of verifying
or disputing any tax returns, reports or related information and disclosures
provided to such taxation authority, or for the Company's or any of its
Subsidiaries' alleged failure to provide any such tax returns, reports or
related information and disclosure. No material claims or deficiencies have been
asserted against or inquiries raised with the Company or any of its Subsidiaries
with respect to any taxes or other governmental charges or levies which have not
been paid or otherwise satisfied, including claims that, or inquiries whether,
the Company or any of its Subsidiaries has not filed a tax return that it was
required to file, and, to the best of the Company's and its Subsidiaries'
knowledge, there exists no reasonable basis for the making of any such claims or
inquiries. Neither the Company nor any of its Subsidiaries has waived any
restrictions on assessment or collection of taxes or consented to the extension
of any statute of limitations relating to taxation.

         (y)      Environmental Matters. None of the premises or any properties
owned, occupied or leased by the Company or its Subsidiaries (the "Premises")
has been used by the Company or the Subsidiaries or, to the Company's knowledge,
by any other Person, to manufacture, treat, store, or dispose of any substance
that has been designated to be a "hazardous substance" under applicable
Environmental Laws (hereinafter defined) ("Hazardous Substances") in violation
of any applicable Environmental Laws. To their knowledge, the Company and its
Subsidiaries have not disposed of, discharged, emitted or released any Hazardous
Substances which would require, under applicable Environmental Laws,
remediation, investigation or similar response activity. No Hazardous Substances
are present as a result of the actions of the Company or its Subsidiaries or, to
the Company's or its Subsidiaries' knowledge, any other Person, in, on or under
the Premises which would give rise to any liability or clean-up obligations of
the Company or its Subsidiaries under applicable Environmental Laws. The Company
and its Subsidiaries and, to the Company's or its Subsidiaries knowledge, any
other Person for whose conduct it may be responsible pursuant to an agreement or
by operation of law, are in compliance with all laws, regulations and other
federal, state or local governmental requirements, and all applicable judgments,
orders, writs, notices, decrees, permits, licenses, approvals, consents or

                                       18
<PAGE>

injunctions in effect on the date of this Agreement relating to the generation,
management, handling, transportation, treatment, disposal, storage, delivery,
discharge, release or emission of any Hazardous Substance (the "Environmental
Laws"). Neither the Company or its Subsidiaries nor, to the Company's or its
Subsidiaries' knowledge, any other Person for whose conduct it may be
responsible pursuant to an agreement or by operation of law has received any
written complaint, notice, order, or citation of any actual, threatened or
alleged noncompliance with any of the Environmental Laws, and there is no
proceeding, suit or investigation pending or, to the Company's or its
Subsidiaries' knowledge, threatened against the Company or its Subsidiaries or,
to the Company's or its Subsidiaries' knowledge, any such Person with respect to
any violation or alleged violation of the Environmental Laws, and, to the
knowledge of the Company or its Subsidiaries, there is no basis for the
institution of any such proceeding, suit or investigation.

         (z)      Somanta Incorporated. The Company has acquired all of the
issued and outstanding capital stock of Somanta Incorporated prior to the date
hereof. The Company had the requisite corporate power and authority to
consummate the acquisition of the capital stock of Somanta Incorporated. There
is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company or its Subsidiaries, threatened
against the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory
authority (federal, state, county, local or foreign) which adversely affects or
challenges the legality, validity or enforceability of the acquisition of the
capital stock of Somanta Incorporated or any agreement or contract entered into
in connection therewith.

         (aa)      Disclosure. All disclosure provided to the Purchasers
regarding the Company or its Subsidiaries, their respective businesses and the
transactions contemplated hereby, including the Disclosure Schedules to this
Agreement, furnished by or on behalf of the Company are true and correct and do
not contain any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements made therein, in light
of the circumstances under which they were made, not misleading.

         3.2      Representations and Warranties of the Purchasers.
                  ------------------------------------------------

         Each Purchaser hereby, for itself and for no other Purchaser,
represents and warrants as of the date hereof and as of the Initial Closing Date
or the Additional Closing Date, as applicable, to the Company as follows:

         (a)      Organization; Authority; Enforceability. Such Purchaser (other
than individuals) is an entity duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization with full power
and authority to enter into and to consummate the transactions contemplated by
the Transaction Documents and otherwise to carry out its obligations thereunder.
The execution, delivery and performance by such Purchaser of the transactions
contemplated by this Agreement has been duly authorized by all necessary
corporate or similar action on the part of such Purchaser. Each Transaction
Document to which it is a party has been duly executed by such Purchaser, and
when delivered by such Purchaser in accordance with the terms hereof, will
constitute the valid and legally binding obligation of such Purchaser,
enforceable against it in accordance with its terms, subject to laws of general
application relating to bankruptcy, insolvency, reorganization, moratorium or
other similar laws affecting creditors' rights generally and rules of law
governing specific performance, injunctive relief, or other equitable remedies.

                                       19
<PAGE>

         (b)      General Solicitation. Such Purchaser is not purchasing the
Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or
similar media or broadcast over television or radio or presented at any seminar
or any other general solicitation or general advertisement.

         (c)      No Public Sale or Distribution. Such Purchaser is (i)
acquiring the Preferred Shares and Warrants and (ii) upon conversion of the
Preferred Stock will acquire the Conversion Shares and upon exercise of the
Warrants will acquire the Warrant Shares, in each case, for its own account and
not with a view towards, or for resale in connection with, the public sale or
distribution thereof; provided, however, that by making the representations
herein, such Purchaser does not agree to hold any of the Securities for any
minimum or other specific term and reserves the right to dispose of the
Securities at any time in accordance with or pursuant to a registration
statement or an exemption under the Securities Act. Such Purchaser is acquiring
the Securities hereunder in the ordinary course of its business. Such Purchaser
does not have any agreement or understanding, directly or indirectly, with any
Person to distribute any of the Securities.

         (d)      Accredited Investor Status. Such Purchaser is an "accredited
investor" as that term is defined in Rule 501(a) of Regulation D.

         (e)      Residency. Such Purchaser is a resident of the jurisdiction
set forth below such Purchaser's name on Schedule 1 attached hereto.

         (f)      Reliance on Exemptions. Such Purchaser understands that the
Preferred Shares and Warrants are being offered and sold to it in reliance on
specific exemptions from the registration requirements of United States federal
and state securities laws and that the Company is relying in part upon the truth
and accuracy of, and such Purchaser's compliance with, the representations,
warranties, agreements, acknowledgments and understandings of such Purchaser set
forth herein in order to determine the availability of such exemptions and the
eligibility of such Purchaser to acquire the Preferred Shares and Warrants.

         (g)      Information. Such Purchaser and its advisors, if any, have
been furnished with all publicly available materials relating to the business,
finances and operations of the Company and such other publicly available
materials relating to the offer and sale of the Preferred Shares and Warrants as
have been requested by such Purchaser or its advisors, if any. Such Purchaser
and its advisors, if any, have been afforded the opportunity to ask questions of
the Company. Neither such inquiries nor any other due diligence investigations
conducted by such Purchaser or its advisors, if any, or its representatives
shall modify, amend or affect such Purchaser's right to rely on the Company's
representations and warranties contained herein. Such Purchaser understands that
its investment in the Preferred Shares and Warrants involves a high degree of
risk.

         (h)      No Governmental Review. Such Purchaser understands that no
United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Preferred
Shares and Warrants or the fairness or suitability of the investment in the

                                       20
<PAGE>

Preferred Shares and Warrants, nor have such authorities passed upon or endorsed
the merits of the offering of the Preferred Shares and Warrants.

         (i)      Experience of Such Purchaser. Such Purchaser, either alone or
together with its representatives, has such knowledge, sophistication and
experience in business and financial matters, including investing in companies
engaged in the business in which the Company is engaged, so as to be capable of
evaluating the merits and risks of the prospective investment in the Preferred
Shares and Warrants, and has so evaluated the merits and risks of such
investment. Such Purchaser is able to bear the economic risk of an investment in
the Preferred Shares and Warrants and, at the present time, is able to afford a
complete loss of such investment.

         The Company acknowledges and agrees that each Purchaser does not make
or has not made any representations or warranties with respect to the
transactions contemplated hereby other than those specifically set forth in this
Section 3.2 and in Section 4.13.

                                   ARTICLE IV

                         OTHER AGREEMENTS OF THE PARTIES

         4.1      Transfer Restrictions.
                  ---------------------

         (a)      The Securities may only be disposed of in compliance with
state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement, to the Company, to
an Affiliate of a Purchaser (who is an accredited investor and executes a
customary representation letter) or in connection with a pledge as contemplated
in Section 4.1(b), the Company may require the transferor thereof to provide to
the Company an opinion of counsel selected by the transferor, the form and
substance of which opinion shall be reasonably satisfactory to the Company, to
the effect that such transfer does not require registration of such transferred
Securities under the Securities Act, provided, however, that in the case of a
transfer pursuant to Rule 144, no opinion shall be required if the transferor
provides the Company with a customary seller's representation letter, and if
such sale is not pursuant to subsection (k) of Rule 144, a customary broker's
representation letter and a Form 144. Any such transferee that agrees in writing
to be bound by the terms of this Agreement and the Investor Rights Agreement
shall have the rights of a Purchaser under this Agreement and the Investor
Rights Agreement. Except as required by federal securities laws and the
securities law of any state or other jurisdiction within the United States, the
Securities may be transferred, in whole or in part, by any of the Purchasers at
any time. The Company shall reissue certificates evidencing the Securities upon
surrender of certificates evidencing the Securities being transferred in
accordance with this Section 4.1(a).

         (b)      The Purchasers agree to the imprinting, so long as is required
by this Section 4.1(b), of a legend on any of the Securities in substantially
the following form:

         THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT

                                       21
<PAGE>

TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO
THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A
FINANCIAL INSTITUTION THAT IS AN "ACCREDITED INVESTOR" AS DEFINED IN RULE 501(a)
UNDER THE SECURITIES ACT.

         The Company acknowledges and agrees that a Purchaser may from time to
time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a
financial institution that is an "accredited investor" as defined in Rule 501(a)
under the Securities Act and, if required under the terms of such arrangement,
such Purchaser may transfer pledged or secured Securities to the pledgees or
secured parties. Such a pledge or transfer would not be subject to approval of
the Company and no opinion of legal counsel of the pledgee, secured party or
pledgor shall be required in connection therewith; provided, however, that such
Purchaser shall provide the Company with such documentation as is reasonably
requested by the Company to ensure that the pledge is pursuant to a bona fide
margin agreement with a registered broker-dealer or a security interest in some
or all of the Securities to a financial institution that is an "accredited
investor" as defined in Rule 501(a) under the Securities Act. The Company will
execute and deliver such documentation as a pledgee or secured party of
Securities may reasonably request in connection with a pledge or transfer of the
Securities, including the preparation and filing of any required prospectus
supplement under Rule 424(b)(3) under the Securities Act or other applicable
provision of the Securities Act to appropriately amend the list of selling
stockholders thereunder.

         (c)      Certificates evidencing the Securities shall not contain any
legend (including the legend set forth in Section 4.1(b)), (i) following any
sale of such Securities pursuant to Rule 144, or (ii) if such Securities are
eligible for sale under Rule 144(k), or (iii) if such legend is not required
under applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the Staff of the Commission). The
Company shall cause its counsel to issue a legal opinion to the Company's
transfer agent promptly upon the occurrence of any of the events in clauses (i),
(ii) or (iii) above to effect the removal of the legend hereunder and shall also
cause its counsel to issue a "blanket" legal opinion to the Company's transfer
agent promptly after the Effective Date, if required by the Company's transfer
agent, to allow sales pursuant to an effective Registration Statement. The
Company agrees that at such time as such legend is no longer required under this
Section 4.1(c), it will, no later than three Trading Days following the delivery
by a Purchaser to the Company or the Company's transfer agent of a certificate
representing Securities issued with a restrictive legend, deliver or cause to be
delivered to such Purchaser a certificate representing such Securities that is
free from all restrictive and other legends. The Company may not make any
notation on its records or give instructions to any transfer agent of the
Company that enlarge the restrictions on transfer set forth in this Section.

                                       22
<PAGE>

         (d)      If within three (3) Trading Days after the Company's receipt,
pursuant to Section 4.1(c), of a legended certificate representing Securities,
the Company shall fail to issue and deliver to such Purchaser a certificate
representing such Securities that is free from all restrictive and other
legends, and if on or after such Trading Day the Purchaser purchases (in an open
market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Purchaser of shares of Common Stock that the
Purchaser anticipated receiving from the Company (the "Sold Anticipated Shares")
without any restrictive legend (a "Buy-In"), then the Company shall, within
three (3) Trading Days after the Purchaser's request and in the Purchaser's sole
discretion, either (i) pay cash to the Purchaser in an amount equal to the
Purchaser's total purchase price (including brokerage commissions, if any) for
the shares of Common Stock so purchased (the "Buy-In Price"), at which point the
Company's obligation to deliver such certificate with respect to the Sold
Anticipated Shares shall terminate and such Securities shall be cancelled, or
(ii) promptly honor its obligation to deliver to the Purchaser a certificate or
certificates representing such Sold Anticipated Shares and pay cash to the
Purchaser in an amount equal to the excess (if any) of (A) the Buy-In Price
minus (B) the product of (1) such number of shares of Common Stock, and (2) the
closing bid price on the date of delivery of such legended certificate.

         (e)      Each Purchaser, severally and not jointly, agrees that the
removal of the restrictive legend from certificates representing Securities as
set forth in this Section 4.1 is predicated upon the Company's reliance on, and
the Purchaser's agreement that, and each Purchaser hereby agrees that, the
Purchaser will not sell any Securities except pursuant to either the
registration requirements of the Securities Act, including any applicable
prospectus delivery requirements, or an exemption therefrom.

         4.2      Furnishing of Information.
                  -------------------------

         As long as any Purchaser owns Securities, the Company covenants to
timely file (or obtain extensions in respect thereof and file within the
applicable grace period) all reports required to be filed by the Company after
the date hereof pursuant to the Exchange Act. Upon the request of any such
holder of Securities, the Company shall deliver to such holder a written
certification of a duly authorized officer as to whether it has complied with
the preceding sentence. As long as any Purchaser owns Securities, if the Company
is not required to file reports pursuant to the Exchange Act, it will prepare
and furnish to the Purchasers and make publicly available in accordance with
Rule 144(c), such information as is required for the Purchasers to sell the
Securities under Rule 144. The Company further covenants that it will take such
further action as any holder of Securities may reasonably request, all to the
extent required from time to time to enable such Person to sell such Securities
without registration under the Securities Act within the limitation of the
exemptions provided by Rule 144.

         4.3      Integration.
                  -----------

         The Company shall not sell, offer for sale or solicit offers to buy or
otherwise negotiate in respect of any security (as defined in Section 2 of the
Securities Act) that would be integrated with the offer or sale of the
Securities in a manner that would require the registration under the Securities
Act of the sale of the Securities to the Purchasers or that would be integrated
with the offer or sale of the Securities for purposes of the rules and
regulations of the OTC Bulletin Board or any Trading Market.

                                       23
<PAGE>

         4.4      Limitation on Future Financing.
                  ------------------------------

         Other than the issuance of Securities at any Additional Closing
pursuant to this Agreement, from the date hereof until the earlier of 120
calendar days after the Initial Closing Date or 15 calendar days after the
Effective Date, the Company shall not effect an issuance of its Common Stock or
Common Stock Equivalents. Notwithstanding anything to the contrary herein, this
Section 4.4 shall not apply to the following: (a) the granting of options or
other equity compensation awards or the issuance of Common Stock or Common Stock
Equivalents to employees, independent contractors, officers and directors of the
Company pursuant to any equity compensation plan duly adopted by a majority of
the non-employee members of the Board of Directors of the Company or a majority
of the members of a committee of non-employee directors established for such
purpose (and the exercise of such options or Common Stock Equivalents), or (b)
the exercise of any security issued by the Company in connection with the offer
and sale of the Company's securities pursuant to this Agreement, or (c) the
exercise of or conversion of any convertible securities, options or warrants
issued and outstanding on the date hereof, or (d) the issuance of Common Stock
or Common Stock Equivalents in connection with acquisitions or strategic
investments, partnerships, business relationship or joint venture, the primary
purpose of which is not to raise capital, or (e) the issuance of securities
pursuant to a stock split or stock dividend or similar capital modification, or
(f) the issuance of securities upon the authorization of the Company's Board of
Directors in connection with business conducted by the Company with vendors,
lessors or financial institutions in connection with financing transactions, or
(g) the issuance of Additional Securities pursuant to the terms of this
Agreement.

         4.5      Publicity.
                  ---------

         No later than 9:30 a.m. (New York City time) on the Trading Day
immediately following execution of this Agreement, the Company shall issue a
press release reasonably acceptable to the SCO Securities LLC disclosing all
material terms of the transactions contemplated hereby. The Company shall,
within four Business Days following the date of this Agreement, file a Current
Report on Form 8-K, disclosing the transactions contemplated hereby and make
such other filings and notices prior to and following the Closing Date in the
manner and time required by the Commission with respect thereto. The Company and
SCO Securities LLC shall consult with each other in issuing any press releases
with respect to the transactions contemplated hereby, and neither the Company
nor any Purchaser shall issue any such press release or otherwise make any such
public statement without the prior consent of the Company, with respect to any
press release of any Purchaser, or without the prior consent of SCO Securities
LLC, with respect to any press release of the Company, except if such disclosure
is required by law, in which case the disclosing party shall promptly provide
the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name
of any Purchaser, or include the name of any Purchaser in any press release or
filing with the Commission (other than the Registration Statement) or any
regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except to the extent such disclosure is required by law or Trading
Market regulations, in which case, to the extent that the Company is permitted
and reasonably able to do so, the Company shall promptly provide the Purchasers
with prior notice of such disclosure.

                                       24
<PAGE>

         4.6      Shareholders Rights Plan.
                  ------------------------

         No claim will be made or enforced by the Company or any other Person
that any Purchaser is an "acquiring person" under any shareholders rights plan
or similar plan or arrangement in effect or hereafter adopted by the Company, or
that any Purchaser could be deemed to trigger the provisions of any such plan or
arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.

         4.7      Non-Public Information.
                  ----------------------

         The Company covenants and agrees that neither it nor any other Person
acting on its behalf will after the date hereof provide any Purchaser or its
agents or counsel with any information that the Company believes constitutes
material non-public information, unless prior thereto such Purchaser shall have
executed a written agreement regarding the confidentiality and use of such
information. The Company understands and confirms that each Purchaser shall be
relying on the foregoing representations in effecting transactions in securities
of the Company.

         4.8      Use of Proceeds.
                  ---------------

         The Company covenants and agrees that the proceeds from the sale of the
Common Stock and Warrants shall be used by the Company for working capital and
general corporate purposes; under no circumstances shall any portion of the
proceeds be applied to:

         (i)      accelerated repayment of debt existing on the date hereof,
except that the Company may prepay the Promissory Note if the aggregate proceeds
actually received by the Company for all Securities sold hereunder is greater
than $6,000,000;

         (ii)     the payment of dividends or other distributions on any capital
stock of the Company;

         (iii)    increased executive compensation (other than in the ordinary
course of business) or loans to officers, employees, stockholders or directors,
unless approved by a majority of the disinterested members of the Board of
Directors;

         (iv)     the purchase of debt or equity securities of any Person,
including the Company and its Subsidiaries, except in connection with investment
of excess cash in high quality (A1/P1 or better) money market instruments having
maturities of one year or less; or

         (v)      any expenditure not directly related to the business of the
Company.

         4.9      Reservation of Preferred Stock and Common Stock.
                  -----------------------------------------------

         As of the date hereof, the Company has reserved and the Company shall
continue to reserve and keep available at all times, free of preemptive rights,
a sufficient number of shares of (a) Preferred Stock for the purpose of enabling
the Company to issue Preferred Shares pursuant to this Agreement and (b) Common

                                       25
<PAGE>

Stock for the purpose of enabling the Company to issue Conversion Shares upon
conversion of the Preferred Stock and Warrant Shares upon exercise of the
Warrants.

         4.10     Listing of Common Stock.
                  -----------------------

         The Company hereby agrees to use commercially reasonable efforts to
maintain the listing of the Common Stock on the OTC Bulletin Board or any
applicable Trading Market, and, if required, to list the applicable Conversion
Shares and Warrant Shares on the OTC Bulletin Board or any applicable Trading
Market in accordance with the applicable rules thereof. The Company further
agrees, if the Company applies to have the Common Stock traded on any other
Trading Market, it will include in such application the Conversion Shares and
the Warrant Shares, and will take such other action as is necessary to cause the
Conversion Shares and Warrant Shares to be listed on such other Trading Market
as promptly as possible.

         4.11     Business Operations. Until the earlier of: (i) the fourth year
anniversary of the Closing Date and (ii) the date that the Purchasers own less
than 50% of the Preferred Shares originally issued pursuant to this Agreement
and the Conversion Shares issued upon any conversion thereof, the Company shall
comply with the following covenants:

         (a)      Insurance. The Company and its Subsidiaries shall maintain
insurance policies such that the representations contained in the first sentence
of Section 3.1(p) hereof continue to be true and correct and shall, from time to
time upon the written request of the Purchasers, promptly furnish or cause to be
furnished to the Purchasers evidence, in form and substance reasonably
satisfactory to the Purchasers, of the maintenance of all insurance maintained
by it.

         (b)      Corporate Existence; Licenses. The Company shall preserve and
maintain and cause its Subsidiaries to preserve and maintain their corporate
existence and good standing in the jurisdiction of their incorporation and the
rights, privileges and franchises of the Company and its Subsidiaries (except,
in each case, in the event of a merger or consolidation in which the Company or
its Subsidiaries, as applicable, is not the surviving entity) in each case where
the failure to so preserve or maintain could have a Material Adverse Effect on
the financial condition, business or operations of the Company and its
Subsidiaries taken as a whole. The Company shall, and shall cause its
Subsidiaries to, maintain at all times all material licenses or permits
necessary to the conduct of its business and as required by any governmental
agency or instrumentality thereof.

         (c)      Taxes and Claims. The Company and its Subsidiaries shall duly
pay and discharge (a) all taxes, assessments and governmental charges upon or
against the Company or its properties or assets prior to the date on which
penalties attach thereto, unless and to the extent that such taxes are being
diligently contested in good faith and by appropriate proceedings, and
appropriate reserves therefor have been established, and (b) all lawful claims,
whether for labor, materials, supplies, services or anything else which might or
could, if unpaid, become a lien or charge upon the properties or assets of the
Company or its Subsidiaries, unless and to the extent only that the same are
being contested in good faith and by appropriate proceedings and appropriate
reserves therefor have been established.

                                       26
<PAGE>

         (d)      Affiliate Transactions. Except for transactions approved by a
majority of the disinterested members of the board of directors of the Company,
neither the Company nor any of its Subsidiaries shall enter into any transaction
with any (i) director, officer, employee or holder of more than 5% of the
outstanding capital stock of any class or series of capital stock of the Company
or any of its Subsidiaries, (ii) member of the immediate family of any such
person, or (iii) corporation, partnership, trust or other entity in which any
such person, or member of the immediate family of any such person, is a
director, officer, trustee, partner or holder of more than 5% of the outstanding
capital stock thereof.

         4.12     Securities Law Compliance.
                  -------------------------

         (a)      Securities Act. The Company shall timely prepare and file with
the Securities and Exchange Commission the form of notice of the sale of
securities pursuant to the requirements of Regulation D regarding the sale of
the Preferred Stock and Warrants under this Agreement.

         (b)      State Securities Law Compliance -- Sale. The Company shall
timely prepare and file such applications, consents to service of process (but
not including a general consent to service of process) and similar documents and
take such other steps and perform such further acts as shall be required by the
state securities law requirements of each jurisdiction where a Purchaser
resides, as indicated on Schedule 1, with respect to the sale of the Preferred
Stock and Warrants under this Agreement.

         (c)      State Securities Law Compliance --Resale. Beginning no later
than 60 days following the date of this Agreement and continuing until either
(i) the Purchasers have sold all of their Registrable Securities (as defined in
the Investor Rights Agreement) under a registration statement pursuant to the
Investor Rights Agreement or (ii) the Common Stock becomes a "covered security"
under Section 18(b)(1)(A) of the Securities Act, the Company shall maintain
within either Moody's Industrial Manual or Standard and Poor's Standard
Corporation Descriptions (or any successors to these manuals which are similarly
qualified as "recognized securities manuals" under state Blue Sky laws) an
updated listing containing (i) the names of the officers and directors of the
Company, (ii) a balance sheet of the Company as of a date that is at no time
older than eighteen months and (iii) a profit and loss statement of the Company
for either the preceding fiscal year or the most recent year of operations.

         4.13     Short Selling. Each Purchaser represents and warrants that it
has not made and agrees that it shall not make any net short sale of the
Company's Common Stock for the period beginning on the fifteenth (15th) day
prior to the date of this Agreement and ending on the earlier of (a) the Closing
Date or (b) the date that the transactions contemplated by this Agreement are
publicly announced. For purposes of this Section 4.13, a "net short sale" by any
Purchaser shall mean a sale of Common Stock by such Purchaser that is marked as
a short sale and that is made at a time when there is no equivalent offsetting
long position in Common Stock held by such Purchaser, where an "equivalent
offsetting long position" includes all shares of Common Stock held by such
Purchaser and all underlying shares of Common Stock which are issuable upon
conversion, exercise or exchange of convertible securities, warrants, options or
other rights to subscribe for or to purchase or exchange for shares of Common
Stock or derivative contracts with respect thereto.

                                       27
<PAGE>

                                    ARTICLE V

                    INDEMNIFICATION, TERMINATION AND DAMAGES

         5.1      Survival of Representations.
                  ---------------------------

         Except as otherwise provided herein, the representations and warranties
of the Company and the Purchasers contained in or made pursuant to this
Agreement shall survive the execution and delivery of this Agreement and the
Closing Date and shall continue in full force and effect for a period of three
(3) years from the Closing Date; provided, however, that the Company's
warranties and representations under Sections 3.1(a) (Subsidiaries), 3.1(b)
(Organization and Qualification), 3.1 (c) (Authorization; Enforceability), and
3.1(g) (Capitalization), shall survive the Closing Date and continue in full
force and effect indefinitely and Sections 3,1(x) (Taxes) and 3.1(y)
(Environmental Matters) shall survive the Closing Date and continue in full
force and effect until the date that is six months following the expiration of
all applicable statutes of limitation. The Company's and the Purchasers'
warranties and representations shall in no way be affected or diminished in any
way by any investigation of (or failure to investigate) the subject matter
thereof made by or on behalf of the Company or the Purchasers.

         5.2      Indemnification. The Company agrees to indemnify and hold
harmless the Purchasers, their Affiliates, each of their officers, directors,
employees and agents and their respective successors and assigns, from and
against any losses, damages, or expenses which are caused by or arise out of (i)
any breach or default in the performance by the Company of any covenant or
agreement made by the Company in this Agreement or in any of the Transaction
Documents; (ii) any breach of warranty or representation made by the Company in
this Agreement or in any of the Transaction Documents; and/or (iii) any and all
third party actions, suits, proceedings, claims, demands, judgments, costs and
expenses (including reasonable legal fees and expenses) incident to any of the
foregoing.

         5.3      Indemnity Procedure.
                  -------------------

         A party or parties hereto agreeing to be responsible for or to
indemnify against any matter pursuant to this Agreement is referred to herein as
the "Indemnifying Party" and the other party or parties claiming indemnity is
referred to as the "Indemnified Party". An Indemnified Party under this
Agreement shall, with respect to claims asserted against such party by any third
party, give written notice to the Indemnifying Party of any liability which
might give rise to a claim for indemnity under this Agreement within sixty (60)
Business Days of the receipt of any written claim from any such third party, but
not later than twenty (20) days prior to the date any answer or responsive
pleading is due, and with respect to other matters for which the Indemnified
Party may seek indemnification, give prompt written notice to the Indemnifying
Party of any liability which might give rise to a claim for indemnity; provided,
however, that any failure to give such notice will not waive any rights of the
Indemnified Party except to the extent the rights of the Indemnifying Party are
materially prejudiced.

                                       28
<PAGE>

         If the Indemnifying Party shall acknowledge in a writing delivered to
the Indemnified Party that the Indemnifying Party shall be obligated under the
terms of their indemnification obligations hereunder in connection with such
third party claim, then the Indemnifying Party shall have the right, at its
election, to take over the defense or settlement of such claim by giving written
notice to the Indemnified Party at least fifteen (15) days prior to the time
when an answer or other responsive pleading or notice with respect thereto is
required. If the Indemnifying Party makes such election, it may conduct the
defense of such claim through counsel of its choosing (subject to the
Indemnified Party's approval of such counsel, which approval shall not be
unreasonably withheld), shall be solely responsible for the expenses of such
defense and shall be bound by the results of its defense or settlement of the
claim. The Indemnifying Party shall not settle any such claim without prior
notice to and consultation with the Indemnified Party, and no such settlement
involving any equitable relief or which might have an adverse effect on the
Indemnified Party may be agreed to without the written consent of the
Indemnified Party (which consent shall not be unreasonably withheld). So long as
the Indemnifying Party is diligently contesting any such claim in good faith,
the Indemnified Party may pay or settle such claim only at its own expense and
the Indemnifying Party will not be responsible for the fees of separate legal
counsel to the Indemnified Party, unless the named parties to any proceeding
include both parties or representation of both parties by the same counsel would
be inappropriate in the reasonable opinion of the Indemnified Party, due to
conflicts of interest or otherwise. If the Indemnifying Party does not make such
election, or having made such election does not, in the reasonable opinion of
the Indemnified Party proceed diligently to defend such claim, then the
Indemnified Party may (after written notice to the Indemnifying Party), at the
expense of the Indemnifying Party, elect to take over the defense of and proceed
to handle such claim in its discretion and the Indemnifying Party shall be bound
by any defense or settlement that the Indemnified Party may make in good faith
with respect to such claim. In connection therewith, the Indemnifying Party will
fully cooperate with the Indemnified Party should the Indemnified Party elect to
take over the defense of any such claim. The parties agree to cooperate in
defending such third party claims and the Indemnified Party shall provide such
cooperation and such access to its books, records and properties as the
Indemnifying Party shall reasonably request with respect to any matter for which
indemnification is sought hereunder; and the parties hereto agree to cooperate
with each other in order to ensure the proper and adequate defense thereof.

         With regard to claims of third parties for which indemnification is
payable hereunder, such indemnification shall be paid by the Indemnifying Party
upon the earlier to occur of: (i) the entry of a judgment against the
Indemnified Party and the expiration of any applicable appeal period, or if
earlier, five (5) days prior to the date that the judgment creditor has the
right to execute the judgment; (ii) the entry of an unappealable judgment or
final appellate decision against the Indemnified Party; or (iii) a settlement of
the claim. Notwithstanding the foregoing, the reasonable expenses of counsel to
the Indemnified Party shall be reimbursed on a current basis by the Indemnifying
Party. With regard to other claims for which indemnification is payable
hereunder, such indemnification shall be paid promptly by the Indemnifying Party
upon demand by the Indemnified Party.

                                       29
<PAGE>

                                   ARTICLE VI

                                  MISCELLANEOUS
                                  -------------

         6.1      Fees and Expenses.
                  -----------------

         The Company shall be responsible for the payment of the Purchasers'
documented legal fees and other third-party expenses relating to the
preparation, negotiation and execution of this Agreement and the Transaction
Documents and the consummation of the transactions contemplated herein,
including any unpaid amounts due and owing to the Purchasers' counsel and
related to services rendered to the Company's subsidiaries in connection with
the Share Exchange Agreement dated as of August 22, 2005, by and among Bridge
Oncology Products, Inc., Somanta Limited and the other signatories thereto.

         6.2      Entire Agreement.
                  ----------------

         The Transaction Documents, together with the exhibits and schedules
thereto, contain the entire understanding of the parties with respect to the
subject matter hereof and supersede all prior agreements and understandings,
oral or written, with respect to such matters, which the parties acknowledge
have been merged into such documents, exhibits and schedules.

         6.3      Notices.
                  -------

         Any and all notices or other communications or deliveries required or
permitted to be provided hereunder shall be in writing and shall be deemed given
and effective on the earliest of (a) the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number specified on
the signature pages attached hereto prior to 5:00 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number on
the signature pages attached hereto on a day that is not a Trading Day or later
than 5:00 p.m. (New York City time) on any Trading Day, (c) the Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight
courier service, or (d) upon actual receipt by the party to whom such notice is
required to be given. The address for such notices and communications shall be
as follows:

         If to the Purchasers, at each Purchaser's address set forth under its
name on Schedule 1 attached hereto, or with respect to the Company, addressed
to:

                  Somanta Pharmaceuticals, Inc.
                  19200 Von Karman Avenue, Suite 400
                  Irvine, CA  92612
                  Attn: Terrance J. Bruggeman, Executive Chairman
                  Fax:  949-706-3698

                                       30
<PAGE>

or to such other address or addresses or facsimile number or numbers as any such
party may most recently have designated in writing to the other parties hereto
by such notice. Copies of notices to the Company shall be sent to:

                  Foley & Lardner LLP
                  402 W. Broadway
                  23rd Floor
                  San Diego, CA 92101
                  Attn: Adam Lenain, Esq.
                  Fax:  619-234-3510

Copies of notices to any Purchaser shall be sent to the addresses, if any,
listed on Schedule 1 attached hereto.

         6.4      Amendments; Waivers.
                  -------------------

         No provision of this Agreement may be waived or amended except in a
written instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement of
any such waiver is sought. No waiver of any default with respect to any
provision, condition or requirement of this Agreement shall be deemed to be a
continuing waiver in the future or a waiver of any subsequent default or a
waiver of any other provision, condition or requirement hereof, nor shall any
delay or omission of either party to exercise any right hereunder in any manner
impair the exercise of any such right. Notwithstanding the foregoing, this
Agreement may be amended by the Company without the consent of the Purchasers
(other than SCO Securities LLC, which must agree pursuant to Section 2.1(c)) by
supplementing Schedule 1 with respect to Purchasers in any Additional Closing
and by adding any such Purchasers as parties to this Agreement in accordance
with Sections 2.1(c) and (d).

         6.5      Construction.
                  ------------

         The headings herein are for convenience only, do not constitute a part
of this Agreement and shall not be deemed to limit or affect any of the
provisions hereof. The language used in this Agreement will be deemed to be the
language chosen by the parties to express their mutual intent, and no rules of
strict construction will be applied against any party.

         6.6      Successors and Assigns.
                  ----------------------

         This Agreement shall be binding upon and inure to the benefit of the
parties and their successors and permitted assigns. The Company may not assign
this Agreement or any rights or obligations hereunder without the prior written
consent of each Purchaser. Any Purchaser may assign any or all of its rights
under this Agreement to any Person, provided such transferee agrees in writing
to be bound, with respect to the transferred Securities, by the provisions
hereof that apply to the Purchasers.

                                       31
<PAGE>

         6.7      No Third-Party Beneficiaries.
                  ----------------------------

         This Agreement is intended for the benefit of the parties hereto and
their respective successors and permitted assigns and is not for the benefit of,
nor may any provision hereof be enforced by, any other Person, except as
otherwise set forth in Article V.

         6.8      Governing Law.
                  -------------

         All questions concerning the construction, validity, enforcement and
interpretation of the Transaction Documents shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York,
without regard to the principles of conflicts of law thereof.

         6.9      Jurisdiction; Venue; Service of Process.
                  ---------------------------------------

         This Agreement shall be subject to the exclusive jurisdiction of the
Federal District Court, Southern District of New York and if such court does not
have proper jurisdiction, the State Courts of New York County, New York. The
parties to this Agreement agree that any breach of any term or condition of this
Agreement shall be deemed to be a breach occurring in the State of New York by
virtue of a failure to perform an act required to be performed in the State of
New York and irrevocably and expressly agree to submit to the jurisdiction of
the Federal District Court, Southern District of New York and if such court does
not have proper jurisdiction, the State Courts of New York County, New York for
the purpose of resolving any disputes among the parties relating to this
Agreement or the transactions contemplated hereby. The parties irrevocably
waive, to the fullest extent permitted by law, any objection which they may now
or hereafter have to the laying of venue of any suit, action or proceeding
arising out of or relating to this Agreement, or any judgment entered by any
court in respect hereof brought in New York County, New York, and further
irrevocably waive any claim that any suit, action or proceeding brought in
Federal District Court, Southern District of New York and if such court does not
have proper jurisdiction, the State Courts of New York County, New York has been
brought in an inconvenient forum. Each of the parties hereto consents to process
being served in any such suit, action or proceeding, by mailing a copy thereof
to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing in this Section 6.9 shall affect or limit
any right to serve process in any other manner permitted by law.

         6.10     Execution.
                  ---------

         This Agreement may be executed in two or more counterparts, all of
which when taken together shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and
delivered to the other party, it being understood that both parties need not
sign the same counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile signature page
were an original thereof.

                                       32
<PAGE>

         6.11     Severability.
                  ------------

         If any provision of this Agreement is held to be invalid or
unenforceable in any respect, the validity and enforceability of the remaining
terms and provisions of this Agreement shall not in any way be affected or
impaired thereby and the parties will attempt to agree upon a valid and
enforceable provision that is a reasonable substitute therefor, and upon so
agreeing, shall incorporate such substitute provision in this Agreement.

         6.12     Replacement of Securities.
                  -------------------------

         If any certificate or instrument evidencing any Securities is
mutilated, lost, stolen or destroyed, the Company shall issue or cause to be
issued in exchange and substitution for and upon cancellation thereof, or in
lieu of and substitution therefor, a new certificate or instrument, but only
upon receipt of evidence reasonably satisfactory to the Company of such loss,
theft or destruction and customary and reasonable indemnity, if requested by the
Company.

         6.13     Remedies.
                  --------

         In addition to being entitled to exercise all rights provided herein or
granted by law, including recovery of damages, each of the Purchasers and the
Company will be entitled to specific performance under the Transaction
Documents. The parties agree that monetary damages may not be adequate
compensation for any loss incurred by reason of any breach of obligations
described in the foregoing sentence and hereby agrees to waive in any action for
specific performance of any such obligation the defense that a remedy at law
would be adequate.

         6.14     Payment Set Aside.
                  -----------------

         To the extent that the Company makes a payment or payments to any
Purchaser pursuant to any Transaction Document or a Purchaser enforces or
exercises its rights thereunder, and such payment or payments or the proceeds of
such enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company,
a trustee, receiver or any other person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation or
part thereof originally intended to be satisfied shall, to the extent
permissible under applicable law, be revived and continued in full force and
effect as if such payment had not been made or such enforcement or setoff had
not occurred.

         6.15     Cancellation of Promissory Note.
                  -------------------------------

        SCO agrees that all of the obligations of Somanta Incorporated and the
Company under the Promissory Note and the Promissory Note itself shall be
cancelled upon the consummation of the Initial Closing and the delivery of the
Preferred Stock and Warrants in consideration for the surrender and cancellation
of the Promissory Note.

         6.16     Independent Nature of Purchasers' Obligations and Rights.
                  --------------------------------------------------------

         The obligations of each Purchaser under any Transaction Document are
several and not joint with the obligations of any other Purchaser, and no
Purchaser shall be responsible in any way for the performance of the obligations
of any other Purchaser under any Transaction Document. Nothing contained herein
or in any Transaction Document, and no action taken by any Purchaser pursuant
thereto, shall be deemed to constitute the Purchasers as a partnership, an
association, a joint venture or any other kind of entity, or create a
presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the
Transaction Document. Each Purchaser shall be entitled to independently protect
and enforce its rights, including without limitation, the rights arising out of

                                       33
<PAGE>

this Agreement or out of the other Transaction Documents, and it shall not be
necessary for any other Purchaser to be joined as an additional party in any
proceeding for such purpose. Each Purchaser has been represented by its own
separate legal counsel in their review and negotiation of the Transaction
Documents. For reasons of administrative convenience only, Purchasers and their
respective counsel have chosen to communicate with the Company through Wiggin
and Dana LLP, but such counsel does not represent any of the Purchasers in this
transaction other than SCO Securities LLC. The Company has elected to provide
all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by the
Purchasers.

         6.17     Waiver of Trial by Jury.
                  -----------------------

         THE PARTIES HERETO IRREVOCABLY WAIVE TRIAL BY JURY IN ANY SUIT, ACTION
OR PROCEEDING RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY.

         6.18     Further Assurances.
                  ------------------

         Each party agrees to cooperate fully with the other parties and to
execute such further instruments, documents and agreements and to give such
further written assurances as may be reasonably requested by any other party to
better evidence and reflect the transactions described herein and contemplated
hereby and to carry into effect the intents and purposes of this Agreement, and
further agrees to take promptly, or cause to be taken, all actions, and to do
promptly, or cause to be done, all things necessary, proper or advisable under
applicable law to consummate and make effective the transactions contemplated
hereby, to obtain all necessary waivers, consents and approvals, to effect all
necessary registrations and filings, and to remove any injunctions or other
impediments or delays, legal or otherwise, in order to consummate and make
effective the transactions contemplated by this Agreement for the purpose of
securing to the parties hereto the benefits contemplated by this Agreement.

                            [Signature Page Follows]

                                       34
<PAGE>


IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
date first above written.

COMPANY:

SOMANTA PHARMACEUTICALS, INC.




By:  /s/ TERRANCE J. BRUGGEMAN
    ---------------------------------------
Name:  Terrance J. Bruggeman
Title: Executive Chairman


                                       35
<PAGE>


PURCHASERS:

ALPHA CAPITAL AG                         Amount of Investment $400,000
                                         Address: Pradafant 7 Furstentums 9490
                                                  Vaduz Liechtenstein
By:  /s/ KONRAD ACKERMANN
     --------------------------
     Konrad Ackermann


BF HOLDING Gmbh                          Amount of Investment $240,000
                                         Address: AM Eulenhof 14
                                                  95326 Kulmbach
By:  /s/ BERND FUERTSCH                           Germany
     --------------------------
     Bernd Fuertsch


LAKE END CAPITAL LLC                     Amount of Investment $250,000
                                         Address: 33 Tall Oaks Drive
                                                  Summit, NJ  07901
By:  /s/ JEFFREY B. DAVIS
     --------------------------
     Jeffrey B. Davis


SCO CAPITAL PARTNERS LLC                 Amount of Investment $2,000,000
                                         Address: 1285 Avenue of the Americas
                                                  35th Floor
By:  /s/ STEVEN H. ROUHANDEH                      New York, NY  10019
     --------------------------
     Steven H. Rouhandeh


WHALEHAVEN CAPITAL FUND LIMITED          Amount of Investment $750,000
                                         Address: 14 Par-La-Ville Road
                                                  3rd Floor
By:  /s/ EVAN SCHEMENAUER                         Hamilton HM08 Bermuda
     --------------------------
     Evan Schemenauer


XMARK OPPORTUNITY FUND LTD.              Amount of Investment $412,500
                                         Address: 301 Tresser Boulevard
                                                  Suite 1320
By:  /s/ MITCHELL D. KAYE                         Stamford, CT  06901
     --------------------------
     Mitchell D. Kaye

                                       36
<PAGE>

XMARK OPPORUNITY FUND, L.P.              Amount of Investment $337,500
                                         Address: 301 Tresser Boulevard
                                                  Suite 1320
By:  /s/ MITCHELL D. KAYE                         Stamford, CT  06901
     --------------------------
     Mitchell D. Kaye


XMARK JR INVESTMENT PARTNERS, LLC        Amount of Investment $250,000
                                         Address: 301 Tresser Boulevard
                                                  Suite 1320
By:  /s/ MITCHELL D. KAYE                         Stamford, CT  06901
     --------------------------
     Mitchell D. Kaye

                    [Omnibus Somanta Pharmaceuticals, Inc.
        Preferred Stock and Warrant Purchase Agreement Signature Page]

                                       37
<PAGE>
<TABLE>
<CAPTION>

                                   Schedule 1
                to Preferred Stock and Warrant Purchase Agreement
              Purchasers and Shares of Preferred Stock and Warrants

--------------------------------------------------------------------------------------------------------------
 Name, Address and Fax                                Shares of        Common Stock
 Number of Purchaser and            Copies of      Preferred Stock      Underlying              Purchase
Registration Instructions          Notices to         Purchased          Warrants                Price
--------------------------------------------------------------------------------------------------------------
<S>                                <C>                  <C>             <C>                  <C>
Alpha Capital AG                                          40              333,333              $  400,000
Pradafant 7 Furstentums 9490
Vaduz Liechtenstein
Telephone: 011-423-232-3195
Fax:  011-423-232-3196
Contact: Konrad Ackermann
--------------------------------------------------------------------------------------------------------------
BF Holding GmbH                                           24              200,000              $  240,000
AM Eulenhof 14
95326 Kulmbach
Germany
Telephone: 49-9221-952-25
Fax:  49-9221-952-17
Contact: Bernd Fuertsch
e-mail:  s.mueller@ucm-ag.de
--------------------------------------------------------------------------------------------------------------
Lake End Capital LLC                                      25              208,333              $  250,000
33 Tall Oaks Drive
Summit, NJ  07901
Telephone: (212) 554-4158
Fax:  (212) 554-4058
Contact: Jeffrey B. Davis
e-mail:  jdavis@scogroup.com
--------------------------------------------------------------------------------------------------------------
</TABLE>

<PAGE>
<TABLE>
<CAPTION>
--------------------------------------------------------------------------------------------------------------
 Name, Address and Fax                                Shares of        Common Stock
 Number of Purchaser and            Copies of      Preferred Stock      Underlying              Purchase
Registration Instructions          Notices to         Purchased          Warrants                Price
--------------------------------------------------------------------------------------------------------------
<S>                                <C>                  <C>             <C>                  <C>
SCO Capital Partners LLC       Michael Grundei, Esq.   328.6318         2,738,598              $2,000,000
1285 Avenue of the Americas,   Wiggin & Dana LLP
35th Floor                     400 Atlantic Street
New York, NY  10019            Stamford, CT  06901                                        and $1,286,318 to be
Telephone: (212) 554-4158      Tel: 203-363-7630                                         paid via cancellation
Fax:  (212) 554-4058           Fax: 203-363-7676                                           of the Promissory
Contact: Steven H. Rouhandeh   e-mail:                                                           Note.
e-mail:                        mgrundei@wiggin.com
srouhandeh@scogroup.com
--------------------------------------------------------------------------------------------------------------
Whalehaven Capital Fund                                   75              625,000              $  750,000
Limited
14 Par-La-Ville Road,
3rd Floor
Hamilton HM08 Bermuda
Telephone: (414) 295-8313
Fax:  (441) 292-1373
Contact: Evan Schemenauer
e-mail:
eschemenauer@consolidated.bm
--------------------------------------------------------------------------------------------------------------
XMark Opportunity Fund Ltd.                              41.25            343,750                 412,500
301 Tresser Blvd., Suite 1320
Stamford, CT  06901
Telephone: (203) 653-2500
Fax:  (203) 653-2501
Contact: Mitchell D. Kaye
e-mail:  mkaye@xmarkfunds.com
--------------------------------------------------------------------------------------------------------------
</TABLE>

                                       2
<PAGE>
<TABLE>
<CAPTION>
--------------------------------------------------------------------------------------------------------------
 Name, Address and Fax                                Shares of        Common Stock
 Number of Purchaser and            Copies of      Preferred Stock      Underlying              Purchase
Registration Instructions          Notices to         Purchased          Warrants                Price
--------------------------------------------------------------------------------------------------------------
<S>                                <C>                  <C>             <C>                  <C>
XMark Opportunity Fund, L.P.                             33.75            281,250                 337,500
301 Tresser Blvd., Suite 1320
Stamford, CT  06901
Telephone:  (203) 653-2500
Fax:  (203) 653-2501
Contact: Mitchell D. Kaye
e-mail:  mkaye@xmarkfunds.com
--------------------------------------------------------------------------------------------------------------
XMark Jr Investment Partners,                             25              208,333                 250,000
LLC
301 Tresser Blvd., Suite 1320
Stamford, CT  06901
Telephone:  (203) 653-2500
Fax:  (203) 653-2501
Contact: Mitchell D. Kaye
e-mail:  mkaye@xmarkfunds.com
--------------------------------------------------------------------------------------------------------------
TOTALS:                                                592.6318         4,938,597              $5,926,318
--------------------------------------------------------------------------------------------------------------

Placement Agent Warrant

SCO Securities LLC             Michael Grundei, Esq.                      987,720
1285 Avenue of the Americas,   Wiggin & Dana LLP
35th Floor                     400 Atlantic Street
New York, NY  10019            Stamford, CT  06901
Contact: Jeffrey B. Davis      Tel:  (203) 363-7630
Telephone: (212) 554-4158      Fax:  (203) 363-7676
Fax:  (212) 554-4058           e-mail:
e-mail:  JDavis@SCOGroup.com   mgrundei@wiggin.com
----------------------------------------------------------------------------------------------------------------
</TABLE>

                                       3